Overview and Chemical Properties

2-Amino-3-Bromo-5-chlorobenzonitrile (CAS number to be confirmed; see review flags) is a trisubstituted benzonitrile bearing an ortho-amino group, a bromo substituent, and a chloro substituent on the aromatic ring. The coexistence of the electron-withdrawing nitrile and halogen groups alongside the electron-donating amino group creates a highly polarized aromatic system, making this compound a versatile bifunctional reagent. The amino group serves as a handle for condensation, acylation, and cyclization reactions, while the bromo and chloro substituents are amenable to transition-metal-catalyzed cross-coupling reactions such as Suzuki–Miyaura, Buchwald–Hartwig, and Negishi couplings. The nitrile group can be hydrolyzed to a carboxylic acid or reduced to an amine, further expanding the synthetic utility of this building block.

Safety and Handling Precautions

Before working with 2-Amino-3-Bromo-5-chlorobenzonitrile, consult the Safety Data Sheet (SDS) provided by Aladdin Scientific. Observe the following precautions:

• Personal Protective Equipment (PPE): Wear chemical-resistant gloves (nitrile recommended), a laboratory coat, and safety goggles at all times. Use a half-face respirator with organic-vapor cartridges if working outside a fume hood.
• Ventilation: All weighing, dissolution, and reaction steps must be conducted inside a certified chemical fume hood to prevent inhalation of dust or vapors.
• Skin and Eye Contact: In case of skin or eye contact, flush immediately with copious amounts of water for at least 15 minutes and seek medical attention.
• Waste Disposal: Halogenated aromatic amines must be disposed of as hazardous chemical waste in accordance with local regulations. Do not pour down the drain.
• Incompatibilities: Keep away from strong oxidizers, strong acids, and strong bases. The amino group is susceptible to oxidation under harsh conditions.

Step-by-Step Protocol: Solution Preparation

The following protocol describes preparation of a stock solution suitable for synthetic or analytical applications:

1. Equilibrate to room temperature: Remove the reagent vial from cold storage and allow it to equilibrate to room temperature (approximately 20–25 °C) for 15–30 minutes before opening to prevent moisture condensation on the solid.
2. Tare the container: Place a clean, dry glass vial or round-bottom flask on an analytical balance and tare to zero.
3. Weigh the compound: Using a micro-spatula, transfer the required amount of 2-Amino-3-Bromo-5-chlorobenzonitrile into the tared container. Record the exact mass. For a 10 mM stock solution in 10 mL DMSO, weigh approximately 23.1 mg of compound.
4. Add solvent: Add anhydrous DMSO (or DMF) in approximately 80% of the final target volume. Cap the vial and vortex or sonicate for 2–5 minutes until complete dissolution is observed. The compound is expected to dissolve readily in polar aprotic solvents.
5. Adjust to final volume: Transfer the solution to a volumetric flask and make up to the final volume with the same solvent. Mix thoroughly.
6. Filter if necessary: If any particulate matter is observed, filter through a 0.22 µm PTFE syringe filter.
7. Label and store: Label the stock solution with compound name, concentration, solvent, date of preparation, and preparer's initials. Store at –20 °C under inert atmosphere (argon or nitrogen) if not used immediately. Use within the period recommended on the SDS.

Typical Synthetic Applications

2-Amino-3-Bromo-5-chlorobenzonitrile serves as a multifunctional platform for constructing complex heterocyclic and carbocyclic frameworks. Representative applications include:

• Suzuki–Miyaura Cross-Coupling: The C–Br bond (being more reactive than C–Cl toward oxidative addition) can be selectively functionalized using palladium catalysts (e.g., Pd(PPh3)4 or Pd(dppf)Cl2) and aryl or vinyl boronic acids in the presence of a base (K2CO3, Cs2CO3) in mixed aqueous-organic solvents.
• Cyclization to Heterocycles: The 1,2-diamine-equivalent motif (amino group ortho to nitrile) facilitates intramolecular cyclization to form benzimidazole, quinazoline, or anthranilic acid derivative scaffolds under appropriate conditions.
• Buchwald–Hartwig Amination: The aryl–halogen bonds can be converted to C–N bonds via palladium-catalyzed amination with primary or secondary amines, enabling rapid diversification of nitrogen-containing pharmacophores.
• Nitrile Group Transformations: The nitrile can be converted to a tetrazole using NaN3/NH4Cl in DMF, to a carboxamide by partial hydrolysis, or to a primary amine by reduction with LiAlH4 or catalytic hydrogenation.

Note: Specific reaction conditions (catalyst loading, temperature, solvent ratios, yields) should be optimized and validated by the end user. Refer to peer-reviewed literature for guidance.

Quality Control and Troubleshooting

Purity Verification: Confirm purity of the received batch by HPLC (reverse-phase C18 column, UV detection at 254 nm) or by NMR (1H and 13C in DMSO-d6 or CDCl3). The compound should display characteristic signals consistent with an aromatic amine bearing nitrile and halogen substituents.

Common Issues and Solutions:

• Poor solubility: If the compound does not dissolve readily, gently warm the solvent to 40–50 °C and sonicate. Do not use aqueous buffers as the primary solvent, as solubility in water is expected to be very low.
• Discoloration of stock solution: Slight yellowing may occur over time due to oxidation of the amino group. Prepare fresh solutions for sensitive applications and store under inert gas.
• Low coupling yields: Ensure rigorous exclusion of oxygen and moisture for cross-coupling reactions. Use freshly degassed solvents and high-purity palladium catalyst.
• Unexpected byproducts: In cross-coupling reactions, both C–Br and C–Cl bonds may react if reaction conditions are too forcing. Use selective conditions and monitor by TLC or LC-MS.